Tango Therapeutics, Inc.
TNGX
$25.60
-$0.05-0.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -55.34M | -45.51M | -38.75M | 15.88M | -38.85M |
| Total Depreciation and Amortization | 425.00K | 463.00K | 479.00K | 555.00K | 625.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.92M | 10.67M | 6.15M | 7.04M | 6.87M |
| Change in Net Operating Assets | -866.00K | -9.98M | 2.40M | -54.43M | -5.16M |
| Cash from Operations | -38.87M | -44.36M | -29.72M | -30.95M | -36.52M |
| Capital Expenditure | -- | -- | -222.00K | -151.00K | -624.00K |
| Sale of Property, Plant, and Equipment | 20.00K | 2.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -445.99M | 9.63M | -135.50M | 47.63M | 17.40M |
| Cash from Investing | -445.97M | 9.64M | -135.72M | 47.48M | 16.78M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 672.66M | 80.38M | 219.41M | 2.54M | 581.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -95.00K | -537.00K | -36.00K | -- | -- |
| Cash from Financing | 672.57M | 79.85M | 219.38M | 2.54M | 581.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 187.73M | 45.12M | 53.94M | 19.07M | -19.16M |